A very important supportive strategy to enhance tumour infiltration by Th1 type immune cells and promote therapeutic virus, or drug spread is to interfere with TGFβ signalling and reduce the ECM density and tumour interstitial pressure. The gene discussed is TGFB1; the disease is neoplasm.